SlideShare a Scribd company logo
Data Integrity – an international
regulatory perspective
Gaye Camm
Senior Inspector, Manufacturing Quality Branch
Medical Devices and Product Quality Division, TGA
ARCS Scientific Congress
11 August 2016
Presentation overview
• What is Data Integrity?
• International regulatory perspective
• Highlights of recent guidance documents
• Common misconceptions
• In summary
Data Integrity – an International Regulatory Perspective 1
What is Data Integrity?
• The extent to which all data are complete, consistent and accurate
throughout the data lifecycle
• From initial data generation and recording through processing
(including transformation or migration), use, retention, archiving,
retrieval and destruction
(MHRA Guidance March 2015)
Data Integrity – an International Regulatory Perspective 2
Data Integrity – International regulatory perspective
• Increased regulatory oversight:
– MHRA guidance document
– FDA Guidance
– Health Canada policy
– WHO guidance
– PIC/S Guidance (anticipated soon)
• Widespread inspectorate training in DI principles and techniques
Data Integrity – an International Regulatory Perspective 3
Data Integrity – International regulatory perspective
• Outcomes:
– Increased focus and scrutiny of data
management practices within industry.
– Increased expectations upon inspectorates
• Leading to:
– Collaboration
Data Integrity – an International Regulatory Perspective 4
International regulatory collaboration
• International convergence in data integrity guidance
• Cooperation between regulators
– Exchange of information
– Joint inspections
– Coordinated market actions
• Inspectorates better equipped to
– Identify data integrity failures
– Manage post-inspection actions
and remediation plans
Data Integrity – an International Regulatory Perspective 5
Regulatory guidance: Common themes
• Guidance promotes quality risk management & lifecycle approach
• ‘Designing systems to comply’ with existing GMP norms
• Integration of behaviour with organisational and technical measures
• Describes common bad practices, and methods of prevention
Data Integrity – an International Regulatory Perspective 6
ALCOA Principles
Attributable
• Clearly
indicates who
recorded the
data or
performed the
activity
• Signed / dated
• Who wrote it /
when
Legible
• It must be
possible to
read or
interpret the
data after it is
recorded
• Permanent
• No
unexplained
hieroglyphics
• Properly
corrected if
necessary
Contemporaneous
• Data must be
recorded at
the time it was
generated
• Close
proximity to
occurrence
Original
• Data must be
preserved in
its unaltered
state
• If not, why not
• Certified
copies
Accurate
• Data must
correctly reflect
the action /
observation
made
• Data checked
where
necessary
• Modifications
explained if not
self-evident
Data Integrity – an International Regulatory Perspective 7
Common misconceptions about Data Integrity
# 1 – Data integrity is a new requirement
Data Integrity – an International Regulatory Perspective 8
Common misconceptions about Data Integrity
# 1 – Data integrity is a new requirement
Basic Data Integrity expectations from the Manufacturing
Principles
• PIC/S Guide PE009-8: Chapter 4 & Annex 11
• Australian Code GMP human blood, blood components,
human tissues and human cellular therapy products:
Sections 400 – 415
• ISO 13485: Sections 4.2.3, 4.2.4
Data Integrity – an International Regulatory Perspective 9
Common misconceptions about Data Integrity
# 2 – Data integrity issues are restricted to certain countries
# 2a – We don’t have these problems in Australia
Data Integrity – an International Regulatory Perspective 10
Common misconceptions about Data Integrity
# 2 – Data integrity issues are restricted to certain countries
• Data Integrity issues have been
reported by every Regulator, in every
country inspected
Data Integrity – an International Regulatory
Perspective
11
Common misconceptions about Data Integrity
# 3 – Data Integrity is all about fraudulent data
Data Integrity – an International Regulatory Perspective 12
Common misconceptions about Data Integrity
# 3 – Data Integrity is all about fraudulent data
Data Integrity is the extent to which data is:
• Complete
• Consistent
• Accurate
Throughout the Data lifecycle
Data Integrity – an International Regulatory Perspective 13
• There was no written description for the site’s computer system that detailed the objectives,
security measures and scope of the system/s, and the main features of the way in which the
systems/s were used and how they interact with other systems (both computerised and non
computerised) and procedures.
• There was no defined procedure for the issue, cancellation and alteration of authorisation to enter
and amend data (i.e. computer systems access).
• No system had been implemented in the QC laboratory to record the identity of operators entering
or confirming critical data as staff in the laboratory used a shared account for each of the
individual computerised data acquisition systems (HPLC, GC, FTIR, and UV/Vis).
• Data associated with QC laboratory data acquisition systems was not adequately secured by
physical or electronic means against willful or accidental damage.
• Data back up frequency for laboratory data acquisition systems was not adequate. The monthly
back up did not ensure that data used to support the release of product for supply would be
readily available throughout the required period of data retention.
Data Integrity – an International Regulatory Perspective 14
Common misconceptions about Data Integrity
# 4 – It’s difficult to comply with data integrity expectations
Data Integrity – an International Regulatory Perspective 15
Data integrity: Risk reducing strategies
Culture Behaviour
Risk identification Risk Lifecycle
Governance Organisational Technical
Operational Procedures,
System design
Data
checking
Computerised
system control
Automation
System
surveillance
Data Integrity – an International Regulatory Perspective 16
Understand vulnerabilities
• Design systems to prevent DI issues
• Ensure the data is authentic and retrievable
• Train staff and encourage correct behaviours and practices
• Open communication
• Encourage feedback
• System for ongoing review
• Not just about your site FRAUD RISK
Incentive/Pressure
Opportunity Attitude/RationalisationData Integrity – an International Regulatory Perspective 17
Summary
• Data Integrity is not a new requirement
• We are all learning & can learn from each other
• Get started
• TGA Data Integrity policy under development
Data Integrity – an International Regulatory Perspective 18
Acknowledgements
Matthew Davis, Senior Inspector, TGA
Stephen Hart, Senior Inspector, TGA
Alicia Mozzachio, Senior Advisor for International Activities US FDA
David Churchward, Expert GMDP Inspector, MHRA
Data Integrity – an International Regulatory Perspective 19
Presentation: Data Integrity – an international regulatory perspective

More Related Content

PPTX
Data integrity: TGA expectations
PPTX
Gdp alcoa
PPT
Data Integrity AbbVie Presentation
PDF
Pharma data integrity
PDF
FDA's top data integrity issues during the inspections
PDF
FDA Data Integrity Issues - DMS hot fixes
PDF
Presentation on data integrity in Pharmaceutical Industry
PPTX
Ensuring data integrity in pharmaceutical environment
Data integrity: TGA expectations
Gdp alcoa
Data Integrity AbbVie Presentation
Pharma data integrity
FDA's top data integrity issues during the inspections
FDA Data Integrity Issues - DMS hot fixes
Presentation on data integrity in Pharmaceutical Industry
Ensuring data integrity in pharmaceutical environment

What's hot (20)

PPTX
Data integrity & ALCOA+
PPTX
Pharmaceutical Data integrity training
PPTX
Delta GMP Data Integrity Sept2016
PDF
Data integrity
PDF
Data integrity
PDF
Data Integrity & Culture of Quality Integration
PDF
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
PPTX
Data Integrity Issues in Pharmaceutical Companies
PPTX
Data integrity in Pharmaceutical Industries
PDF
Data Integrity webinar - Essentials & Solutions
 
PPTX
Data integrity in Pharmaceutical industry
PPTX
Data integrity challenges and solutions
PDF
Data integrity Presentation@GCC Regulatory Summit April-2017
PDF
Data integrity nishodh 01092016
PDF
FDA Data Integrity: Misconceptions of 21 CFR Part 11
PPTX
Data Integrity
PPTX
Lab data integrity
PDF
Data integrity in pharmaceutical industry a brief overview
PDF
Data Integrity Training by Dr. A. Amsavel
PPTX
Data Integrity in FDA Regulated Labs
Data integrity & ALCOA+
Pharmaceutical Data integrity training
Delta GMP Data Integrity Sept2016
Data integrity
Data integrity
Data Integrity & Culture of Quality Integration
Data Integrity; Ensuring GMP Six Systems Compliance Pharma Training
Data Integrity Issues in Pharmaceutical Companies
Data integrity in Pharmaceutical Industries
Data Integrity webinar - Essentials & Solutions
 
Data integrity in Pharmaceutical industry
Data integrity challenges and solutions
Data integrity Presentation@GCC Regulatory Summit April-2017
Data integrity nishodh 01092016
FDA Data Integrity: Misconceptions of 21 CFR Part 11
Data Integrity
Lab data integrity
Data integrity in pharmaceutical industry a brief overview
Data Integrity Training by Dr. A. Amsavel
Data Integrity in FDA Regulated Labs
Ad

Viewers also liked (8)

PPTX
Manufacturing Quality Branch – 2015 Achievements and Challenges
PPTX
Presentation: Release for supply, packaging - in house and contract
PDF
Presentation Trends in Australian and international regulation and regulatory...
PPTX
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
PPTX
Good Practices for Computerised Systems : PIC/S Guidance
PPTX
Presentation on US FDA Data Integrity Guidance.
PPTX
PPTX
Computer System Validation
Manufacturing Quality Branch – 2015 Achievements and Challenges
Presentation: Release for supply, packaging - in house and contract
Presentation Trends in Australian and international regulation and regulatory...
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
Good Practices for Computerised Systems : PIC/S Guidance
Presentation on US FDA Data Integrity Guidance.
Computer System Validation
Ad

Similar to Presentation: Data Integrity – an international regulatory perspective (20)

PPTX
TGA presentation: Data Integrity - an international regulatory perspective
PPTX
Data Integrity Concepts - Without Logo.pptx
PDF
Data integrity - Regulatory Perspective and Challenges:
PPTX
DATA INTEGRITY GMP COMPLIANCE
PPTX
Data Integrity
PPTX
GDocP, Data governance & Data Integrity.pptx
PPTX
Quick Overview: Pharmaceutical Data Integrity
PPTX
DI-GCP.pptx
PPTX
Data Integrity.pptx
PPTX
Data Integrity in a GxP-regulated Environment - Pauwels Consulting Academy
PPTX
Data integrity nouri 10092020
PDF
Pharmaceutical Data Integrity@IBA Karachi
PPT
Data Integrity : A Basic Concept of data recording and analysis
PPTX
New PICS Guidance on Data Integrity and Management.
PDF
Regulatory Intelligence
PDF
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
PPTX
MHRA Data Integrity Requirements
PPTX
Q-Pulse & Data Integrity
PPTX
Data Integrity
PPTX
Data Integrity.pptx
TGA presentation: Data Integrity - an international regulatory perspective
Data Integrity Concepts - Without Logo.pptx
Data integrity - Regulatory Perspective and Challenges:
DATA INTEGRITY GMP COMPLIANCE
Data Integrity
GDocP, Data governance & Data Integrity.pptx
Quick Overview: Pharmaceutical Data Integrity
DI-GCP.pptx
Data Integrity.pptx
Data Integrity in a GxP-regulated Environment - Pauwels Consulting Academy
Data integrity nouri 10092020
Pharmaceutical Data Integrity@IBA Karachi
Data Integrity : A Basic Concept of data recording and analysis
New PICS Guidance on Data Integrity and Management.
Regulatory Intelligence
A Perspective Study of Warning Letters on Data Integrity Issued by FDA betwee...
MHRA Data Integrity Requirements
Q-Pulse & Data Integrity
Data Integrity
Data Integrity.pptx

More from TGA Australia (20)

PPTX
Pharmacovigilance and complementary medicines - Regulatory requirements
PPTX
The challenges of regulating direct to consumer digital medical devices
PPTX
Updates from the Pharmacovigilance and Special Access Branch
PPTX
Consumer Medicine Information - Improving the CMI template
PPTX
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
PPTX
Improved electronic submission methodologies - Challenges and future state
PPTX
Regulation, ethics and reimbursement of novel biological therapies in Austral...
PPTX
Updates to Good Manufacturing Practices - Recent, current and future changes
PPTX
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
PPTX
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Reporting of Medicine Shortages
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 1
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 2
PPTX
SME Assist: Help to navigate the regulatory maze
PPTX
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
PPTX
Presentation: Updates from the Pharmacovigilance and Special Access Branch
PPTX
Presentation: The challenges of regulating direct to consumer digital medical...
PPTX
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Pharmacovigilance and complementary medicines - Regulatory requirements
The challenges of regulating direct to consumer digital medical devices
Updates from the Pharmacovigilance and Special Access Branch
Consumer Medicine Information - Improving the CMI template
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Improved electronic submission methodologies - Challenges and future state
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Updates to Good Manufacturing Practices - Recent, current and future changes
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
Reporting of Medicine Shortages
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 2
SME Assist: Help to navigate the regulatory maze
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
Presentation: Updates from the Pharmacovigilance and Special Access Branch
Presentation: The challenges of regulating direct to consumer digital medical...
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018

Recently uploaded (20)

PPTX
1 General Principles of Radiotherapy.pptx
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
ACID BASE management, base deficit correction
PPTX
Acid Base Disorders educational power point.pptx
PPTX
CME 2 Acute Chest Pain preentation for education
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
Neuropathic pain.ppt treatment managment
PPTX
surgery guide for USMLE step 2-part 1.pptx
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
Fundamentals of human energy transfer .pptx
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
1 General Principles of Radiotherapy.pptx
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
ACID BASE management, base deficit correction
Acid Base Disorders educational power point.pptx
CME 2 Acute Chest Pain preentation for education
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Neuropathic pain.ppt treatment managment
surgery guide for USMLE step 2-part 1.pptx
Human Health And Disease hggyutgghg .pdf
Fundamentals of human energy transfer .pptx
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
DENTAL CARIES FOR DENTISTRY STUDENT.pptx

Presentation: Data Integrity – an international regulatory perspective

  • 1. Data Integrity – an international regulatory perspective Gaye Camm Senior Inspector, Manufacturing Quality Branch Medical Devices and Product Quality Division, TGA ARCS Scientific Congress 11 August 2016
  • 2. Presentation overview • What is Data Integrity? • International regulatory perspective • Highlights of recent guidance documents • Common misconceptions • In summary Data Integrity – an International Regulatory Perspective 1
  • 3. What is Data Integrity? • The extent to which all data are complete, consistent and accurate throughout the data lifecycle • From initial data generation and recording through processing (including transformation or migration), use, retention, archiving, retrieval and destruction (MHRA Guidance March 2015) Data Integrity – an International Regulatory Perspective 2
  • 4. Data Integrity – International regulatory perspective • Increased regulatory oversight: – MHRA guidance document – FDA Guidance – Health Canada policy – WHO guidance – PIC/S Guidance (anticipated soon) • Widespread inspectorate training in DI principles and techniques Data Integrity – an International Regulatory Perspective 3
  • 5. Data Integrity – International regulatory perspective • Outcomes: – Increased focus and scrutiny of data management practices within industry. – Increased expectations upon inspectorates • Leading to: – Collaboration Data Integrity – an International Regulatory Perspective 4
  • 6. International regulatory collaboration • International convergence in data integrity guidance • Cooperation between regulators – Exchange of information – Joint inspections – Coordinated market actions • Inspectorates better equipped to – Identify data integrity failures – Manage post-inspection actions and remediation plans Data Integrity – an International Regulatory Perspective 5
  • 7. Regulatory guidance: Common themes • Guidance promotes quality risk management & lifecycle approach • ‘Designing systems to comply’ with existing GMP norms • Integration of behaviour with organisational and technical measures • Describes common bad practices, and methods of prevention Data Integrity – an International Regulatory Perspective 6
  • 8. ALCOA Principles Attributable • Clearly indicates who recorded the data or performed the activity • Signed / dated • Who wrote it / when Legible • It must be possible to read or interpret the data after it is recorded • Permanent • No unexplained hieroglyphics • Properly corrected if necessary Contemporaneous • Data must be recorded at the time it was generated • Close proximity to occurrence Original • Data must be preserved in its unaltered state • If not, why not • Certified copies Accurate • Data must correctly reflect the action / observation made • Data checked where necessary • Modifications explained if not self-evident Data Integrity – an International Regulatory Perspective 7
  • 9. Common misconceptions about Data Integrity # 1 – Data integrity is a new requirement Data Integrity – an International Regulatory Perspective 8
  • 10. Common misconceptions about Data Integrity # 1 – Data integrity is a new requirement Basic Data Integrity expectations from the Manufacturing Principles • PIC/S Guide PE009-8: Chapter 4 & Annex 11 • Australian Code GMP human blood, blood components, human tissues and human cellular therapy products: Sections 400 – 415 • ISO 13485: Sections 4.2.3, 4.2.4 Data Integrity – an International Regulatory Perspective 9
  • 11. Common misconceptions about Data Integrity # 2 – Data integrity issues are restricted to certain countries # 2a – We don’t have these problems in Australia Data Integrity – an International Regulatory Perspective 10
  • 12. Common misconceptions about Data Integrity # 2 – Data integrity issues are restricted to certain countries • Data Integrity issues have been reported by every Regulator, in every country inspected Data Integrity – an International Regulatory Perspective 11
  • 13. Common misconceptions about Data Integrity # 3 – Data Integrity is all about fraudulent data Data Integrity – an International Regulatory Perspective 12
  • 14. Common misconceptions about Data Integrity # 3 – Data Integrity is all about fraudulent data Data Integrity is the extent to which data is: • Complete • Consistent • Accurate Throughout the Data lifecycle Data Integrity – an International Regulatory Perspective 13
  • 15. • There was no written description for the site’s computer system that detailed the objectives, security measures and scope of the system/s, and the main features of the way in which the systems/s were used and how they interact with other systems (both computerised and non computerised) and procedures. • There was no defined procedure for the issue, cancellation and alteration of authorisation to enter and amend data (i.e. computer systems access). • No system had been implemented in the QC laboratory to record the identity of operators entering or confirming critical data as staff in the laboratory used a shared account for each of the individual computerised data acquisition systems (HPLC, GC, FTIR, and UV/Vis). • Data associated with QC laboratory data acquisition systems was not adequately secured by physical or electronic means against willful or accidental damage. • Data back up frequency for laboratory data acquisition systems was not adequate. The monthly back up did not ensure that data used to support the release of product for supply would be readily available throughout the required period of data retention. Data Integrity – an International Regulatory Perspective 14
  • 16. Common misconceptions about Data Integrity # 4 – It’s difficult to comply with data integrity expectations Data Integrity – an International Regulatory Perspective 15
  • 17. Data integrity: Risk reducing strategies Culture Behaviour Risk identification Risk Lifecycle Governance Organisational Technical Operational Procedures, System design Data checking Computerised system control Automation System surveillance Data Integrity – an International Regulatory Perspective 16
  • 18. Understand vulnerabilities • Design systems to prevent DI issues • Ensure the data is authentic and retrievable • Train staff and encourage correct behaviours and practices • Open communication • Encourage feedback • System for ongoing review • Not just about your site FRAUD RISK Incentive/Pressure Opportunity Attitude/RationalisationData Integrity – an International Regulatory Perspective 17
  • 19. Summary • Data Integrity is not a new requirement • We are all learning & can learn from each other • Get started • TGA Data Integrity policy under development Data Integrity – an International Regulatory Perspective 18
  • 20. Acknowledgements Matthew Davis, Senior Inspector, TGA Stephen Hart, Senior Inspector, TGA Alicia Mozzachio, Senior Advisor for International Activities US FDA David Churchward, Expert GMDP Inspector, MHRA Data Integrity – an International Regulatory Perspective 19